T-Mobile US Insider Bought Shares Worth $1,977,836, According to a Recent SEC Filing-March 2024-www.financetom.com

T-Mobile US Insider Bought Shares Worth $1,977,836, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

T-Mobile US Insider Bought Shares Worth $1,977,836, According to a Recent SEC Filing

Nov 10, 2025 1:53 PM

04:36 PM EST, 11/10/2025 (MT Newswires) -- Srini Gopalan, Director, President and CEO, on November 06, 2025, executed a purchase for 9,800 shares in T-Mobile US ( TMUS ) for $1,977,836. Following the Form 4 filing with the SEC, Gopalan has control over a total of 90,258 common shares of the company, with 90,258 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1283699/000128369925000162/xslF345X05/wk-form4_1762810429.xml

Previous page： Alignment Healthcare Insider Sold Shares Worth $1,303,141, According to a Recent SEC Filing Next page： Cytomx Therapeutics Insider Sold Shares Worth $764,138, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Alignment Healthcare Insider Sold Shares Worth $1,303,141, According to a Recent SEC Filing

Mar 20, 2026

04:24 AM EDT, 03/20/2026 (MT Newswires) -- John E Kao, Director, Chief Executive Officer, on March 18, 2026, sold 73,046 shares in Alignment Healthcare ( ALHC ) for $1,303,141. Following the Form 4 filing with the SEC, Kao has control over a total of 4,257,509 common shares of the company, with 1,784,868 shares held directly and 2,472,641 controlled indirectly. SEC...

Cytomx Therapeutics Insider Sold Shares Worth $764,138, According to a Recent SEC Filing

Mar 20, 2026

04:25 AM EDT, 03/20/2026 (MT Newswires) -- Sean A. McCarthy, Director and Chief Executive Officer, on March 17, 2026, sold 118,969 shares in Cytomx Therapeutics ( CTMX ) for $764,138. Following the Form 4 filing with the SEC, McCarthy has control over a total of 1,172,080 common shares of the company, with 1,078,922 shares held directly and 93,158 controlled indirectly....

Market Chatter: Novo Nordisk Weight-Loss Patents Set to Expire, Paving Way for Cheap Generics

Mar 20, 2026

04:24 AM EDT, 03/20/2026 (MT Newswires) -- Novo Nordisk's ( NVO ) weight-loss drugs in India are about to face steep price cuts after the introduction of generic versions this month with the expiration of patents, Bloomberg reported Friday. At least 12 companies are expected to immediately launch injectable versions of semaglutide with prices as low as 1,290 ($13.82) rupees...

Roivant Sciences Insider Sold Shares Worth $5,648,000, According to a Recent SEC Filing

Mar 20, 2026

04:24 AM EDT, 03/20/2026 (MT Newswires) -- Eric Venker, President and Immunovant Chief Executive Officer, on March 17, 2026, sold 200,000 shares in Roivant Sciences ( ROIV ) for $5,648,000. Following the Form 4 filing with the SEC, Venker has control over a total of 1,647,546 common shares of the company, with 1,647,546 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1635088/000163508826000026/xslF345X05/wk-form4_1773959801.xml ...